Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 232

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 232
---
 and regulations. By submitting an application for the Class A Ordinary
Shares, you represent and warrant to us that you are an Exempt Investor.

As any offer of Class A Ordinary Shares under
this prospectus will be made without disclosure in Australia under Chapter 6D.2 of the Corporations Act, the offer of those securities
for resale in Australia within 12 months may, under section 707 of the Corporations Act, require disclosure to investors under
Chapter 6D.2 if none of the exemptions in section 708 applies to that resale. By applying for the Class A Ordinary Shares you
undertake to us that you will not, for a period of 12 months from the date of issue of the Class A Ordinary Shares, offer, transfer,
assign or otherwise alienate those securities to investors in Australia except in circumstances where disclosure to investors is not required
under Chapter 6D.2 of the Corporations Act or where a compliant disclosure document is prepared and lodged with ASIC.

<div align='center'>132</div>

Notice to Prospective Investors in Canada

Resale restrictions.The distribution of
the Class A Ordinary Shares in Canada is being made only in the provinces of Ontario, Quebec, Alberta and British Columbia on a private
placement basis exempt from the requirement that we prepare and file a prospectus with the securities regulatory authorities in each
province where trades of the Class A Ordinary Shares are made. Any resale of the Class A Ordinary Shares in Canada must be made under
applicable securities laws which may vary depending on the relevant jurisdiction, and which may require resales to be made under available
statutory exemptions or under a discretionary exemption granted by the applicable Canadian securities regulatory authority. Purchasers
are advised to seek legal advice prior to any resale of the securities.

Representations of Canadian purchasers.By
purchasing Class A Ordinary Shares in Canada and accepting delivery of a purchase confirmation, a purchaser is representing to us and
the dealer from whom the purchase confirmation is received that:

| ● | the purchaser is entitled under applicable provincial securities laws to purchase the Class A Ordinary Shares without the benefit of a prospectus qualified under those securities laws as it is an “accredited investor” as defined under National Instrument 45-106 — Prospectus Exemptions; |

| ● | the purchaser is a “permitted client” as defined                                                          
 in National Instrument 31-103 — Registration Requirements, Exemptions and Ongoing Registrant Obligations; |

| ● | where required by law, the